Ishita Drugs & Industries Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Ishita Drugs & Industries Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
28.54% Fall from 52W High
-22.4
TTM PE Ratio
Above industry Median
32.6
Price to Book Ratio
Below industry Median
2.3
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-2
RSI
RSI is mid-range
50.5
MFI
MFI is mid-range
52.9

Ishita Drugs & Industries Ltd shareholding Pattern

Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.2%
Promoter
49.3%
Public
50.3%

Ishita Drugs & Industries Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
12
5Day EMA
70.40
10Day EMA
70.40
12Day EMA
70.40
20Day EMA
70.20
26Day EMA
70.20
50Day EMA
70.60
100Day EMA
71.30
200Day EMA
69.80
5Day SMA
70.30
10Day SMA
70.50
20Day SMA
70.70
30Day SMA
68.90
50Day SMA
70.40
100Day SMA
73.00
150Day SMA
72.20
200Day SMA
72.20
Delivery & Volume
Resistance & Support
70.44
Pivot
Resistance
First Resistance
71.76
Second Resistance
73.23
Third Resistance
74.55
Support
First Support
68.97
Second support
67.65
Third Support
66.18
Relative Strength Index
50.51
Money Flow Index
52.89
MACD
0.22
MACD Signal
0.23
Average True Range
3.05
Average Directional Index
15.19
Rate of Change (21)
3.40
Rate of Change (125)
8.55
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Ortin Laboratories Ltd.
15.89
16.15
30.33
Ishita Drugs & Industries Ltd.
-
-
-
Beryl Drugs Ltd.
-
-
-
Decipher Labs Ltd.
-
-
-
Zenith Healthcare Ltd.
-
-
-
Gujarat Inject (Kerala) Ltd.
-
-
-
Dipna Pharmachem Ltd.
-
-
-

Ishita Drugs & Industries Ltd Company background

Founded in: 1992
Managing director: Jagdish Agrawal
Ishita Drugs Industries Limited was incorporated in Feb.92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a stateofart manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms.The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana).Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.95. It established an inhouse RD laboratory which has developed a highly improved process technology for norfloxacin, which was implemented in the plant during Oct.95.The Company in 2009 undertook a small expansion cumdebottlenecking project it upgraded many existing equipments.
Read More

Ishita Drugs & Industries Ltd FAQs

You can easily buy Ishita Drugs & Industries Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage